Quantcast
Viewing all articles
Browse latest Browse all 24331

InVivo goes from illiquid to a top-traded stock: 5 key notes

InVivo Therapeutics' stock is heating up as the company begins to launch the Neuro-Spinal Scaffold trial at more sites across the United States, according to a Microcap Daily report.


Viewing all articles
Browse latest Browse all 24331

Trending Articles